TY  - JOUR
AU  - Voorham, Jaco
AU  - Baldi, Simonetta
AU  - Santoro, Luigi
AU  - Kerkhof, Marjan
AU  - Contoli, Marco
AU  - Fabbri, Leonardo M
AU  - Kerstjens, Huib A M
AU  - Luis López-Campos, Jose
AU  - Roche, Nicolas
AU  - Singh, Dave
AU  - Vogelmeier, Claus F
AU  - Price, David B
PY  - 2020
DO  - 10.2147/COPD.S269287
UR  - http://hdl.handle.net/10668/16549
T2  - International journal of chronic obstructive pulmonary disease
AB  - This study aimed to evaluate the non-inferiority of initiating extrafine beclometasone dipropionate/formoterol fumarate (BDP/FF) versus double bronchodilation (long-acting beta-agonists [LABA]/long-acting muscarinic antagonists [LAMA]) among patients...
LA  - en
KW  - chronic obstructive pulmonary disease
KW  - comparative effectiveness
KW  - electronic health records
KW  - heterogeneity
KW  - observational
KW  - real-world
KW  - Administration, Inhalation
KW  - Adrenergic beta-2 Receptor Agonists
KW  - Aged
KW  - Beclomethasone
KW  - Bronchodilator Agents
KW  - Cohort Studies
KW  - Formoterol Fumarate
KW  - Humans
KW  - Male
KW  - Muscarinic Antagonists
KW  - Pulmonary Disease, Chronic Obstructive
TI  - Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study.
TY  - research article
VL  - 15
ER  -